These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 21398049

  • 1. Low-dose radiotherapy in indolent lymphoma.
    Rossier C, Schick U, Miralbell R, Mirimanoff RO, Weber DC, Ozsahin M.
    Int J Radiat Oncol Biol Phys; 2011 Nov 01; 81(3):e1-6. PubMed ID: 21398049
    [Abstract] [Full Text] [Related]

  • 2. Palliation by low-dose local radiation therapy for indolent non-Hodgkin lymphoma.
    Chan EK, Fung S, Gospodarowicz M, Hodgson D, Wells W, Sun A, Pintile M, Tsang RW.
    Int J Radiat Oncol Biol Phys; 2011 Dec 01; 81(5):e781-6. PubMed ID: 21167657
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas.
    Haas RL, Poortmans P, de Jong D, Aleman BM, Dewit LG, Verheij M, Hart AA, van Oers MH, van der Hulst M, Baars JW, Bartelink H.
    J Clin Oncol; 2003 Jul 01; 21(13):2474-80. PubMed ID: 12829665
    [Abstract] [Full Text] [Related]

  • 5. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM).
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206
    [Abstract] [Full Text] [Related]

  • 6. Outcome of hyperfractionated radiotherapy in chemotherapy-resistant non-Hodgkin's lymphoma.
    Martens C, Hodgson DC, Wells WA, Sun A, Bezjak A, Pintilie M, Crump M, Gospodarowicz MK, Tsang R.
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1183-7. PubMed ID: 16376490
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
    Guo Y, Lu JJ, Ma X, Wang B, Hong X, Li X, Li J.
    Oral Oncol; 2008 Jan 15; 44(1):23-30. PubMed ID: 17306611
    [Abstract] [Full Text] [Related]

  • 9. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
    Bessell EM, Graus F, Lopez-Guillermo A, Lewis SA, Villa S, Verger E, Petit J.
    Int J Radiat Oncol Biol Phys; 2004 Jun 01; 59(2):501-8. PubMed ID: 15145169
    [Abstract] [Full Text] [Related]

  • 10. Radiotherapy for stage I-III nodal low-grade non-Hodgkin's lymphoma.
    Ott OJ, Rödel C, Gramatzki M, Niedobitek G, Sauer R, Grabenbauer GG.
    Strahlenther Onkol; 2003 Oct 01; 179(10):694-701. PubMed ID: 14566478
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
    Dawson LA, Saito NG, Ratanatharathorn V, Uberti JP, Adams PT, Ayash LJ, Reynolds CM, Silver SM, Schipper MJ, Lichter AS, Eisbruch A.
    Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):208-18. PubMed ID: 15093918
    [Abstract] [Full Text] [Related]

  • 13. Long-term outcome of localized high-grade non-Hodgkin's lymphoma treated with high dose CHOP regimen and involved field radiotherapy: results of a GOELAMS study.
    Bernard M, Cartron G, Rachieru P, LeMevel A, Branger B, Le Maignan C, Berthou C, Ghandour C, Delwail V, Milpied N, Cassasus P, Celigny PS, Guyotat D, Lamy T, Desablens B, French GOELAMS Group.
    Haematologica; 2005 Jun 01; 90(6):802-9. PubMed ID: 15951293
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Low-dose involved-field radiation in the treatment of non-hodgkin lymphoma: predictors of response and treatment failure.
    Russo AL, Chen YH, Martin NE, Vinjamoori A, Luthy SK, Freedman A, Michaelson EM, Silver B, Mauch PM, Ng AK.
    Int J Radiat Oncol Biol Phys; 2013 May 01; 86(1):121-7. PubMed ID: 23414765
    [Abstract] [Full Text] [Related]

  • 17. Long-term follow-up of a prospective study of combined modality therapy for stage I-II indolent non-Hodgkin's lymphoma.
    Seymour JF, Pro B, Fuller LM, Manning JT, Hagemeister FB, Romaguera J, Rodriguez MA, Ha CS, Smith TL, Ayala A, Hess M, Cox JD, Cabanillas F, McLaughlin P.
    J Clin Oncol; 2003 Jun 01; 21(11):2115-22. PubMed ID: 12775737
    [Abstract] [Full Text] [Related]

  • 18. A phase I/II study examining pentostatin, chlorambucil, and theophylline in patients with relapsed chronic lymphocytic leukemia and non-Hodgkin's lymphoma.
    Willis CR, Goodrich A, Park K, Waselenko JK, Lucas M, Reese A, Diehl LF, Grever MR, Byrd JC, Flinn IW.
    Ann Hematol; 2006 May 01; 85(5):301-7. PubMed ID: 16518606
    [Abstract] [Full Text] [Related]

  • 19. Radiotherapy for low-grade gastric marginal zone lymphoma: a retrospective study.
    Lin ML, Wirth A, Chao M, Milner AD, DiIulio J, MacManus M, Seymour JF.
    Intern Med J; 2007 Mar 01; 37(3):172-80. PubMed ID: 17316336
    [Abstract] [Full Text] [Related]

  • 20. Bendamustine with or without rituximab in the treatment of relapsed chronic lymphocytic leukaemia: an Italian retrospective study.
    Iannitto E, Morabito F, Mancuso S, Gentile M, Montanini A, Augello A, Bongarzoni V, D'Arco A, Di Renzo N, Fazzi R, Franco G, Marasca R, Mulè A, Musso M, Musto P, Pennese E, Piccin A, Rota-Scalabrini D, Visani G, Rigacci L.
    Br J Haematol; 2011 May 01; 153(3):351-7. PubMed ID: 21371003
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.